Navigation Links
Paramedics can provide an effective alternative to standard ambulance service in the community
Date:10/5/2007

Paramedics with extended skills can provide a safe and effective alternative to standard ambulance transfer and hospital treatment for older people with a minor injury or illness, finds a study published on bmj.com today.

Older people make up to 21% of visits to hospital emergency departments and previous studies have suggested that paramedics can be trained to manage certain conditions in the community. But current research evidence concerning safety, effectiveness and costs to support these changes in practice is lacking.

So researchers based in South Yorkshire carried out the first randomised trial to evaluate the effectiveness of an alternative approach to managing older people with minor problems.

They selected seven experienced paramedics who had completed the Paramedic Practitioner in Older Peoples Support (PPOPS) training course. This scheme aims to deliver patient centred care to older people calling the emergency services with conditions judged to be not immediately life threatening.

The trial took place in Sheffield from September 2003 to September 2004 and included 3,018 patients aged 60 years and above calling the emergency services between 0800-2000hrs with a complaint that fell within the scope of practice of the paramedic practitioners. These included falls, lacerations, nosebleeds or minor burns.

During each week, a paramedic practitioner based in the ambulance control room identified eligible calls and notified either a paramedic practitioner in the community (intervention weeks) or in the emergency department for the standard 999 service (control weeks).

Emergency department attendance or hospital admission between 0 and 28 days was recorded, as was interval from time of call to time of discharge. Patient satisfaction with the service they had received was also measured using a postal questionnaire 3 and 28 days after the incident.

Patients in the intervention group were almost 25% less likely to attend the emergency department or require hospital admission within 28 days. These patients also experienced a shorter total episode time by around 42 minutes.

Patients in the intervention group were also more likely to report being highly satisfied with their health care episode than those in the control group.

There were no statistically significant differences between the two groups in terms of health outcomes and mortality 28 days after their initial episode.

Despite some study limitations, the authors conclude that this service conveyed significant benefits for patients and the NHS in terms of reduced overall emergency department and hospital attendances, shorter episode times and higher levels of patient satisfaction. The new service also appears to be safe in that they identified no difference in mortality or health outcomes after 28 days.

As pressure increases within the NHS to extend this type of approach, this trial will help to inform practice in this fast developing area, they add.

This trial shows that high quality study designs are feasible in this setting, says an accompanying editorial. Such trials should, therefore, be used to evaluate the more widespread emergency care practitioners scheme and other extended scope paramedic programmes before further costly expansions take place.


'/>"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
Source:Eurekalert

Related medicine news :

1. Paramedics save more lives following unconventional rules
2. Careless Paramedics Spread Infection
3. Expand the Role of Paramedics to Ensure Future of EMS in Canada
4. Protein provides antioxidant protection to Neurons
5. Acupuncture provides relief
6. Micro-camera provides new breast imaging technique
7. Hormone therapy provides no heart benefit
8. Clothes may provide better protection against sun-related skin problems in children
9. MicroRNA provides new insight into birth defects
10. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
11. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... , ... SuperCloset is proud to officially launch our “Helping Veterans Grow ... and obstacles veterans’ need to overcome in order to face their life changes upon ... veteran(s) with a donated SuperCloset product based on the needs and ability of helping ...
(Date:5/27/2016)... ... ... More than a third of American adults are considered obese, says the ... increased attention in recent years, as an article published May 18th on ... people are familiar with the basic requirements of maintaining a healthy diet and exercise ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute ... for a sustainable product to aid in the rehabilitation process has steadily increased. Ekso ... of individuals with hemiplegia due to stroke. , Ekso Bionics has now received clearance ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... health care world, this installment is bolstered by inspiring human interest stories, courtesy ... to the developing trends and tech within the industry, from leading advocates and ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... and Orphan Diseases, today announced that President & CEO Gerald ... SeeThru Equity MicroCap Conference   Where: ... , NY When: Tuesday, May 31 st , ... Where: Grand Hyatt Hotel, 109 East 42 nd St, ...
(Date:5/26/2016)... May 26, 2016   Change Healthcare ... analytics, network solutions and technology-enabled services designed ... entered into a strategic channel partnership with ... software solutions and revenue cycle management services ... and rehabilitation clinics to optimize revenue, operational ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: